Although previous reports indicate that methylation differences over 10% in Illumina assays reach biological significance and have a low probability of being technical artifacts [35, 36], this remains theoretical, and the work here, unfortunately, does not demonstrate the functional significance of HOOK2 methylation in patients with T2D. The gene discussed is HOOK2; the disease is type 2 diabetes mellitus.